Acute Kidney Injury Evaluation

Acute kidney injury (AKI) is a sudden, often reversible decline in kidney function that serves as a critical marker of illness severity across hospital and outpatient settings. Its prompt evaluation is not merely an academic exercise but a vital clinical skill, as delayed recognition directly contributes to increased mortality, prolonged hospital stays, and the risk of progressing to chronic kidney disease. Mastering the systematic approach to AKI allows you to rapidly identify its cause, initiate targeted treatment, and prevent further renal damage.

Defining and Classifying Acute Kidney Injury

Acute kidney injury is clinically defined as a rapid reduction in kidney function, leading to the accumulation of waste products like creatinine and urea in the blood. The key diagnostic criteria focus on changes from a patient's baseline: an absolute increase in serum creatinine of $\ge 0.3$ mg/dL within 48 hours, a $\ge 50\%$ increase in serum creatinine within 7 days, or a documented reduction in urine output to less than $0.5$ mL/kg/hr for more than 6 hours. These criteria, formalized by the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines, provide a uniform standard for diagnosis and staging (Stages 1-3), which correlates with prognosis.

The foundational concept is the abrupt decline in the glomerular filtration rate (GFR), the best overall index of kidney function. While GFR is not directly measured in urgent settings, the rise in serum creatinine is used as a surrogate marker. It's crucial to understand that AKI is a syndrome with multiple potential causes, not a single disease. The initial clinical imperative is to determine why the GFR has fallen so that therapy can be correctly directed.

The Three Etiological Categories of AKI

All causes of AKI can be logically organized into three broad categories based on the anatomical site of the problem: prerenal, intrinsic renal, and postrenal. This framework is your diagnostic roadmap.

Prerenal AKI is the most common form and results from inadequate blood flow to the kidneys. Think of it as a "pump" or "pipe" problem. The kidney parenchyma itself is initially normal but is underperfused. Causes include true volume depletion (e.g., vomiting, diarrhea, hemorrhage), effective arterial blood volume depletion (e.g., heart failure, cirrhosis), or medications that disrupt renal blood flow autoregulation (e.g., NSAIDs, ACE inhibitors). The kidney responds by conserving sodium and water, making this state often rapidly reversible with restoration of renal perfusion.

Intrinsic Renal AKI involves direct damage within the kidney. This category is subdivided by the affected structure: the vasculature (e.g., vasculitis, malignant hypertension), glomeruli (e.g., glomerulonephritis), the tubules (e.g., acute tubular necrosis (ATN) from ischemia or toxins), or the interstitium (e.g., allergic interstitial nephritis from drugs like antibiotics). ATN is the most common cause of in-hospital intrinsic AKI, typically following a severe or prolonged prerenal insult or exposure to a nephrotoxin.

Postrenal AKI is caused by obstruction of the urinary flow after it leaves the kidneys. This can occur at any level, from the renal pelvis (e.g., kidney stones) to the urethra (e.g., prostatic hyperplasia). Obstruction creates backpressure that eventually suppresses GFR. It is crucial to identify because relief of the obstruction can lead to dramatic recovery of function.

The Diagnostic Approach: History, Exam, and Key Labs

Your evaluation begins with a focused history and physical. Ask about fluid intake/output, recent illnesses, medication use (prescription, over-the-counter, herbal), and symptoms of obstruction (e.g., flank pain, anuria, hesitancy). On exam, assess volume status (orthostatic vitals, jugular venous pressure, edema), look for signs of systemic disease (rash, arthritis), and perform a rectal or pelvic exam if obstruction is suspected.

Urinalysis is a cornerstone test. A bland urinalysis with few cells or casts suggests prerenal or postrenal causes. Muddy brown granular casts are classic for ATN. Red blood cell casts point to glomerulonephritis, while white blood cell casts and eosinophiluria suggest interstitial nephritis. Measuring urine electrolytes is the next critical step, primarily to distinguish prerenal from intrinsic AKI.

This is where the fractional excretion of sodium (FE Na) becomes indispensable. It calculates the percentage of filtered sodium that is excreted in the urine, reflecting the kidney's handling of sodium. The formula is:

$$FENa=\frac{(UrineNa/SerumNa)}{(UrineCreatinine/SerumCreatinine)}\times 100\%$$

In prerenal states, the intact tubules avidly reabsorb sodium to preserve volume, resulting in a low FE Na (typically <1%). In intrinsic AKI like ATN, the damaged tubules cannot reabsorb sodium efficiently, leading to a higher FE Na (usually >2%). A major caveat is that FE Na can be low in certain intrinsic causes like glomerulonephritis, early obstruction, or with concurrent diuretic use. In diuretic-treated patients, the fractional excretion of urea (FE Urea) < 35% may be a more reliable indicator of a prerenal state.

Management Principles: From Resuscitation to Replacement

Management flows directly from the diagnosed etiology. For prerenal AKI, the cornerstone is volume resuscitation. This may involve intravenous fluids or, in cases of cardiogenic prerenal AKI (heart failure), careful diuresis and afterload reduction to improve cardiac output. Removing offending agents like NSAIDs is also key.

Management of intrinsic AKI is primarily supportive, focusing on treating the underlying cause (e.g., immunosuppression for vasculitis, stopping an offending drug in interstitial nephritis), avoiding further nephrotoxins, and managing complications. These complications include fluid overload, hyperkalemia, metabolic acidosis, and uremia. When these cannot be managed medically, renal replacement therapy (RRT), such as hemodialysis, is required. The decision to initiate RRT is based on the clinical picture, not a single lab value.

For postrenal AKI, the goal is to relieve the obstruction, which may require a urinary catheter, ureteral stenting, or percutaneous nephrostomy. Renal function often improves quickly post-relief, though a post-obstructive diuresis must be monitored.

Common Pitfalls

1. Relying solely on FE Na without clinical context. As noted, a low FE Na does not rule out intrinsic disease. Always correlate with the history, medication list, and urinalysis. In a patient on diuretics, consider FE Urea.
2. Missing postrenal obstruction. Failure to check for obstruction, especially in an older male with anuria or severe lower abdominal discomfort, is a critical error. A quick bladder scan or post-void residual can be diagnostic. Remember, obstruction can be partial and may not cause anuria.
3. Delaying nephrology consultation for complex cases. While initial stabilization is your priority, early involvement of a nephrologist is crucial for guiding the workup of intrinsic diseases (e.g., when to biopsy) and managing advanced complications.
4. Overlooking the transition from prerenal to ATN. A severe or prolonged prerenal insult is the most common cause of ATN. A patient who does not respond to adequate volume resuscitation has likely developed intrinsic injury, necessitating a shift in management strategy.

Summary

• Acute kidney injury is a rapid decline in GFR, classified into three categories: prerenal (low renal blood flow), intrinsic renal (parenchymal damage), and postrenal (urinary obstruction).
• The fractional excretion of sodium (FE Na) is a key diagnostic tool to differentiate prerenal (FE Na <1%) from intrinsic causes like ATN (FE Na >2%), but its interpretation must account for diuretic use and clinical context.
• Prerenal AKI is often reversible with volume resuscitation, while management of intrinsic AKI is supportive and may require renal replacement therapy for life-threatening complications.
• A systematic evaluation—including a meticulous history, physical exam, urinalysis, and assessment for obstruction—is essential for early recognition and treatment of the underlying cause, which directly improves patient outcomes.